Euclid Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-39,190
Closed -$2.87M 102
2016
Q2
$2.87M Sell
39,190
-2,130
-5% -$152K 0.12% 233
2016
Q1
$2.92M Sell
41,320
-8,060
-16% -$536K 0.11% 237
2015
Q4
$3.29M Buy
+49,380
New +$3.28M 0.1% 230
2015
Q3
Sell
-31,627
Closed -$2.07M 265
2015
Q2
$2.07M Sell
31,627
-76,849
-71% -$5.21M 0.04% 308
2015
Q1
$7.52M Sell
108,476
-580,935
-84% -$40.2M 0.14% 164
2014
Q4
$47.7M Buy
689,411
+26,631
+4% +$1.8M 0.44% 54
2014
Q3
$43.2M Buy
662,780
+71,120
+12% +$4.69M 0.31% 71
2014
Q2
$40.3M Buy
+591,660
New +$39.7M 0.28% 82
2014
Q1
Sell
-480,120
Closed -$31.3M 411
2013
Q4
$31.3M Buy
+480,120
New +$30.7M 0.26% 84
2013
Q3
Sell
-368,280
Closed -$21.1M 481
2013
Q2
$21.1M Buy
+368,280
New +$21.9M 0.27% 90

Other funds holding CL

Euclid Advisors's CL Position: Q3 2016 in Review

Euclid Advisors sold out of Colgate-Palmolive (CL) in Q3 2016, closing a stake of 39,190 shares — an estimated $2.87M sold.

Euclid Advisors first reported a position in CL in Q2 2013 and held it in 10 quarters. The position peaked at $47.7M in Q4 2014. 1,299 funds tracked by Wall St. Rank hold CL as of Q3 2016.

  • Euclid Advisors reported no remaining Colgate-Palmolive position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 39,190 Colgate-Palmolive shares in Q3 2016, an estimated $2.87M.
  • Euclid Advisors first reported a position in Colgate-Palmolive in Q2 2013 and held it in 10 quarters.
  • Euclid Advisors's Colgate-Palmolive position peaked at $47.7M in Q4 2014.
  • 1,299 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.